NCT03565237View on ClinicalTrials.gov

RIXUBIS PMS India (RIXUBIS PMS)

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 7, 2018

Primary Completion Date

August 11, 2021

Study Completion Date

August 11, 2021

Conditions
Hemophilia B
Interventions
BIOLOGICAL

RIXUBIS: On-Demand

RIXUBIS used under standard clinical practice in India: On-Demand treatment.

BIOLOGICAL

RIXUBIS: Prophylaxis

RIXUBIS used under standard clinical practice in India: Prophylaxis treatment.

Trial Locations (1)

411004

Sahyadri Super Speciality Hospital, Pune

All Listed Sponsors
collaborator

Baxalta Innovations GmbH, now part of Shire

INDUSTRY

lead

Baxalta now part of Shire

INDUSTRY

NCT03565237 - RIXUBIS PMS India (RIXUBIS PMS) | Biotech Hunter | Biotech Hunter